Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterised by airflow obstruction and increasing breathlessness. 1 It is the fourth leading cause of death worldwide 2;3 and is associated with high healthcare utilisation costs; costing the UK National
Health Service (NHS) more than £800 million annually. 4 However the additional societal costs attributable to the condition, mainly deriving from lower work productivity, are even greater, with estimates ranging from £1.1 billion and £2.7 billion annually. 4;5 In the UK, an estimated 44% of the COPD population are below retirement age, and around one quarter
are not in work due to their COPD. 5 For those who are in employment, an estimated 5% of sickness absence is due to COPD. 5 A number of studies have indicated that patients with COPD have lower employment rates compared to those without COPD, [6] [7] [8] and this appears to be more marked amongst those with more severe disease. 8 Furthermore, COPD may also be responsible for increased absenteeism 9 and presenteeism 10 (poor work performance when at work).
However, studies examining the effect of COPD on employment and work productivity are not always consistent, and have been conducted in a variety of settings and populations.
There are no previous comprehensive reviews of the evidence in this area. The aim of this review was to summarise the findings of these studies and to identify the key disease related factors that are associated with poorer working outcomes among those with COPD.
This will inform the development of future interventions to help improve work productivity within this population.
Methods
We undertook a systematic review to evaluate the evidence on the relationship between COPD and employment, absenteeism and presenteeism. Cohort or cross-sectional studies of COPD patients from any setting, which measured employment, absenteeism or presenteeism among COPD patients compared with participants without COPD were sought.
To ensure that the effect of disease severity was considered, only studies where a standardised measure of disease severity or impact of symptoms was used were considered.
A comprehensive search was conducted using CINAHL, Embase, MEDLINE and The Cochrane
Library electronic databases to identify relevant studies published from 1937 until August 2017. The combination of keywords used were: ("chronic obstructive pulmonary disease" or "COPD" or "chronic obstructive airways disease" or "chronic obstructive lung disease" or "emphysema" or "chronic bronchitis") and ("employment" or "employed" or "absenteeism"
or "day off" "sickness absence" or "sick leave" or "presenteeism" or "work productivity" or "work performance" or "occupational health"). MeSH terms and text words were used. All relevant epidemiological studies were included. Citation lists were scanned to identify additional relevant articles. Non-English language articles were excluded.
One reviewer (KR) screened all titles and abstracts and relevant full-text articles. The shortlisted citations were independently assessed by another reviewer (RJ). The first reviewer extracted the data using an agreed data extraction form. For a random sample of 45% of papers, a second reviewer checked data extraction. Outcome measures of interest included: objective or subjectively reported employment, absenteeism (including mean number of days or hours off work; proportion of patients reporting time off work) and presenteeism (including mean presenteeism score; number of hours affected by presenteeism; proportion of patients reporting presenteeism). Due to the various definitions we used a known definition of presenteeism for the purpose of this review: "the problem of workers being on the job, but, because of illness or other medical conditions, not fully functioning"
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; therefore studies measuring the impact of COPD on work performance or working limitations were included, irrespective of whether a validated presenteeism tool was used. Articles that did not compare those with COPD to those without COPD or assess the effect of disease severity on one of the three outcomes measures were excluded. For studies that did not report data in the text or tables, estimates were extracted from graphs or calculated using the available data (i.e. proportions).
The methodological quality of the included studies was assessed by the first reviewer, with a random sample of 45% of papers, checked by the second reviewer using an adaptation of the Cochrane risk of bias method 12 and a combination of questions from Crombie 13 and the Critical Appraisal Skills Programme (CASP) cohort tool 14 ; which was piloted and adjusted as necessary (see supplementary table S2 for quality assessment criteria). Risk of bias was classified as high, low or unclear.
Results
Of 3108 citations (after excluding duplicate citations), 44 relevant studies met the inclusion criteria. The effect of COPD on employment was assessed in 20 studies 64.6% in 1994-96).
Two further cross-sectional studies showed that those with COPD and chronic bronchitis had higher rates of early retirement, compared with those without COPD 30 and those who had asthma symptoms. 20 The final four cross-sectional studies compared COPD with other respiratory conditions. A general population study (n=8855), found that those with self-reported emphysema had higher unemployment (62.9%) compared to those with chronic bronchitis (18.4%) and asthma (25.2%), with a higher proportion also attributing this to their lung condition (27.4% vs. 0.6% and 4.8% respectively). 31 The remaining three studies were part of a series based on the same protocol carried out in India, 16 Among 7 cross-sectional studies assessing effects of airflow obstruction, only 3 found a statistically significant inverse relationship with employment, 8;21;28 including one high quality study, from the USA which adjusted for a range of confounders. 8 Another cross-sectional study, based on a large (n=2139) primary/secondary care population with COPD, indicated trends of lower employment and higher early retirement with increasing airflow obstruction, however no statistical tests were reported. 30 The remaining studies showed no association and were of varying quality.
Three studies assessed other measures of disease severity: symptoms score 15 (breathlessness, coughing, infection, mucous production and wheezing), modified Medical
Research Council (mMRC) score 17;26 and the body-mass index, airflow obstruction, dyspnoea and exercise capacity (BODE) index. 26 All showed lower employment rates with increasing severity, including one study which adjusted for all relevant confounders. 35 ), and found a significantly increased risk of disability in those with COPD compared to those without. Data on disability days were extracted from the employee's company database, however the definitions lacked clarity.
Five studies 20;30;31;42;44 reported the proportion of COPD patients affected by sickness absence and one 45 reported the proportion of those with absenteeism who had airflow limitation. All used self-reported absenteeism and recall periods varied from two weeks 31 to six years. 42 The cohort study found higher absenteeism among people with, compared to those without COPD over six years (95.5% vs. 82.4%). 42 Of the three cross-sectional studies, two found that a greater proportion of people with COPD or airflow limitation reported absenteeism (over 12 months) compared to those without. 30;45 Two further studies found higher absenteeism among those with asthma compared to those with COPD, but neither adjusted for confounding.
19;43
Nine cross-sectional studies assessed whether work time missed over one-week differed among those with, from those without COPD (n=4) or with other respiratory diseases (n=5). Four of the five cross-sectional studies that compared the risk of absenteeism in those with COPD or airflow limitation with those without, had similar trends. The remaining Canadian study found no significant difference between those with and without COPD. 49 However, there was a lack of adjustment for important potential confounders. Performance Questionnaire (WHO-HPQ). 9;50 Although both found no significant association, one suggested COPD patients might be at increased risk of presenteeism.
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A serial cross-sectional study based in a large US company obtained data over two time periods using two presenteeism questionnaires: the Work Limitation Questionnaire (WLQ) and the Health and Work Productivity-One Survey (HWP-1). 32 The study found that presenteeism was greater among those with COPD compared to matched cases who did not have COPD at the 1 st time point (p<0.05), although no significant association was seen at the other time point.
One cross-sectional study based on an employed Japanese population of 1378 people, consisting of a smaller sample of people with airflow limitation (n=98), assessed the impact of airflow limitation on perceived quantity and quality of work, 45 43 Furthermore, when measuring disability-related work loss, there was clear evidence from a cohort study that COPD patients were approximately twice as likely to have a short term disability and more than 4 times as likely to have long term disability compared to those without COPD. 35 The evidence for associations between disease severity (measured by airflow obstruction) and absenteeism was inconsistent, and comparison of study findings was difficult due to methodological weaknesses (e.g. small sample sizes, lack of adjustment for confounders), differences in measures of disease severity, and measures of absenteeism. There was however, increasing evidence from adjusted analyses that absenteeism was worse among people with greater symptoms.
For presenteeism, there was weak evidence that patients with COPD had poorer work performance than those without, with some inconsistency in findings. Due to the various scales used to measure presenteeism it was difficult to quantify these differences. Some of the inconsistencies may be attributable to gender and age differences between samples. 32 There was conflicting evidence on the effect of disease severity on work performance, in particular the relationship with airflow obstruction. Similar to the data on absenteeism, analyses using other measures of disease severity did show significant associations with work performance; of which the majority were adjusted for the effect of confounding.
There were some well-conducted observational studies included in this review, which either matched or adjusted for a range of important covariates. However, adjustment for confounders or important confounders was an identified problem among many studies, making it difficult to interpret the reported effect sizes. Additionally, some studies did not go beyond descriptive statistics and hence, reported no effect size. Many studies also displayed limited external validity. This is the first comprehensive systematic review, assessing the effect of COPD on workrelated outcomes. However, the review had some limitations. Firstly, it was restricted to publications in English. Only one reviewer screened all citations from the electronic databases. A standardised tool was not available to evaluate the methodological strength of the evidence. However, to our knowledge, there is currently no gold-standard tool to assess bias within cross-sectional studies. There was high heterogeneity between the studies, making it difficult to compare and synthesise the results.
Two other reviews have been published 55;56 ; despite the differences in the methodology of these compared to the current review, the main results were broadly similar. However, Patel et al's 56 study focused on studies within the USA, and little was discussed on the effects of COPD disease severity on work outcomes in Chaker et al's study. 55 Due to the methodological weaknesses found within the current literature, the following are required for future studies: prospective studies with matched controls or better control of confounders; use of validated scales; methods of data collection to minimise recall error (e.g. routine data on sickness absence, or data from company records) and robust methods in diagnosing lung disease (i.e. spirometry data). Future studies should measure work performance using an agreed and standardised questionnaire and recall periods, to allow comparisons between studies.
Whilst the effect of airflow obstruction on outcomes was unclear, we did find associations between other measures of disease severity and employment, absenteeism and presenteeism. 15;26;41;46 This supports findings from other literature that other measures, such as extent of breathlessness, may be more important for assessing severity in relation to impact on outcomes in patients with COPD.
Poorer employment and work productivity among people with COPD may be partly attributable to their work conditions or to poor disease management. It is important to raise awareness among employers and for better liaison between the workplace and the employees' health providers. Employers could provide support by ensuring access to smoking cessation programmes and time for employees to attend relevant selfmanagement programmes. 1 They could also support employees by undertaking workplace risk assessments and adjusting their work tasks to reduce the risk of triggering exacerbations. 57 By promoting the health of employees with chronic disease, employers will not only benefit the patient, but also improve work productivity in their workforce.
This review highlighted the lack of strong evidence on the effect of COPD on presenteeism, and suggests that the presence of symptoms rather than airflow obstruction impact on outcomes. Longitudinal studies, using standardised instruments and sufficient data to adjust for confounders, are required to confirm these observations. There is also a need to understand how to support COPD patients to remain in work and improve their work productivity. In order to inform interventions, we need to understand which modifiable aspects of the disease, personal or work characteristics contribute to the burden of COPD on work. Such interventions are needed to benefit both the physical and mental health and wellbeing of patients, as well as to benefit society.
Key points:
 Patients with chronic obstructive pulmonary disease have lower employment rates and take more time off work compared to those without COPD.

There is conflicting evidence about the effects of airflow obstruction on work-related outcomes, however there is evidence that symptoms are important; longitudinal studies are needed to confirm this.
Better understanding of the modifiable factors associated with lower employment rates and poorer work productivity are needed to help design effective interventions.
Further research is required, particularly prospective studies which account for relevant confounders, use robust methods in diagnosing COPD, measure absenteeism and presenteeism using agreed and standardised questionnaires and recall periods, and allow comparison of data between studies. 
